Nextech Invest Ltd.

The portfolio is exceptionally top-heavy, with the single largest position accounting for more than half of the total assets. Furthermore, the firm demonstrates a strong preference for liquidity in its strategy, evidenced by the fact that 13 out of 15 positions remained completely unchanged during the quarter. This suggests a buy-and-hold approach rather than active short-term trading.

2. Key Holdings

The most defining feature of this portfolio is the overwhelming dominance of Revolution Medicines Inc (RVMD). With a market value of $332.47 million, this single position constitutes 53.94% of the entire portfolio. Nextech increased this stake by 20.7% during the quarter, adding $46.91 million. This massive allocation indicates that the firm views RVMD as a cornerstone asset with significant upside potential, likely driving the bulk of the fund's future performance.